The current novel molecular DNA cloning procedure – during which a given DNA fragment (DNA stretch subjected to cloning, also called “insert”) aimed to be multiplied is introduced into a vector DNA (“vehicle”) without using in vitro added enzymes such as restriction endonucleases, ligases, DNA polymerases and 5′ exonucleases – is particularly suitable for generating novel DNA constructs in a relatively fast and cost-effective way, as it performs DNA cloning without using in vitro added enzymes.
Mycoplasma anserisalpingitidis is a pathogen lurking in geese which poses a threat primarily to the health of geese and, less commonly, ducks.
The invention relates to a process and an apparatus for treating biomass which, by efficiently processing the biomass, achieves an efficiency increase of 15-20% compared to existing solutions in terms of energy requirements of the process making it self-sustaining by omitting traditional energy-intensive technologies used for roasting biomass, such as vacuum and inert gases, in a way that the biomass fed to the kiln is heat-treated in an oxygen-free environment created by its own biogas.
The present invention relates to a newly isolated strain of PPV1. The invention further relates to the use of the novel strain PPV1 for eliciting an immune response. The invention further relates to the use of the new strain PPV1 for the preparation of vaccine compositions.
Porcine parvovirus 2 (PPV2) is a member of a recently discovered worldwide group of porcine parvoviruses and is often detected in the background of respiratory symptoms, suggesting a pathological role for the virus in the disease.